lapatinib has been researched along with chlorhexidine in 1 studies
| Studies (lapatinib) | Trials (lapatinib) | Recent Studies (post-2010) (lapatinib) | Studies (chlorhexidine) | Trials (chlorhexidine) | Recent Studies (post-2010) (chlorhexidine) |
|---|---|---|---|---|---|
| 1,919 | 305 | 1,442 | 9,521 | 2,099 | 3,952 |
| Protein | Taxonomy | lapatinib (IC50) | chlorhexidine (IC50) |
|---|---|---|---|
| perilipin-5 | Homo sapiens (human) | 4.0045 | |
| perilipin-1 | Homo sapiens (human) | 2.2083 | |
| ubiquitin-conjugating enzyme E2 N | Homo sapiens (human) | 2.6045 | |
| melanocortin receptor 4 | Homo sapiens (human) | 1.997 | |
| 1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a | Homo sapiens (human) | 3.5425 | |
| hexokinase HKDC1 | Homo sapiens (human) | 8.99 | |
| Synaptojanin-2 | Homo sapiens (human) | 10 | |
| Solute carrier family 22 member 2 | Homo sapiens (human) | 0.4 | |
| Solute carrier family 22 member 1 | Homo sapiens (human) | 0.21 | |
| Solute carrier family 22 member 3 | Homo sapiens (human) | 0.41 | |
| 72 kDa type IV collagenase | Homo sapiens (human) | 7.63 | |
| Matrix metalloproteinase-9 | Homo sapiens (human) | 7.63 | |
| Multidrug and toxin extrusion protein 2 | Homo sapiens (human) | 0.5 | |
| Multidrug and toxin extrusion protein 1 | Homo sapiens (human) | 0.7 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
1 other study(ies) available for lapatinib and chlorhexidine
| Article | Year |
|---|---|
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |